Results 61 to 70 of about 3,788,205 (194)

Prospective study of symptoms of ovarian cancer in postmenopausal women [PDF]

open access: yes, 2010
Background: Research has identified key symptoms of ovarian cancer, although there are gaps in the knowledge about the pattern of symptom onset, severity and frequency. Previous studies are limited by use of non-validated questionnaires, recall bias and
Allen, P.L.
core  

p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker [PDF]

open access: yes, 2010
The oncolytic adenovirus dl922-947 replicates selectively within and lyses cells with a dysregulated Rb pathway, a finding seen in > 90% human cancers.
Balkwill, F.R.   +39 more
core   +1 more source

Development of A Mouse Model of Menopausal Ovarian Cancer

open access: yesFrontiers in Oncology, 2014
Despite significant understanding of the genetic mutations involved in ovarian epithelial cancer and advances in genomic approaches for expression and mutation profiling of tumor tissues, several key questions in ovarian cancer biology remain enigmatic:
Elizabeth R. Smith   +2 more
doaj   +1 more source

Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review

open access: yesGynecologic Oncology Reports, 2017
Despite a good initial response to chemotherapy, the majority of patients with epithelial ovarian cancer will eventually recur and die of their disease.
Haller J. Smith   +3 more
doaj   +1 more source

Upregulation of SENP3/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis

open access: yesTumor Biology, 2017
As a crucial member of the small ubiquitin-like modifier system, SUMO-specific protease 3, was identified to be essential for cell proliferation and ribosomal RNA processing.
Jialin Cheng   +10 more
doaj   +1 more source

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma [PDF]

open access: yes, 2003
BACKGROUND: We wished to evaluate the clinical response following ATP-Tumor Chemosensitivity Assay (ATP-TCA) directed salvage chemotherapy in a series of UK patients with advanced ovarian cancer. The results are compared with that of a similar assay used
Pauline A Whitehouse   +36 more
core   +2 more sources

Treatment of recurrent epithelial ovarian cancer

open access: yesTherapeutics and Clinical Risk Management, 2009
Carmela Pisano, Giovanni S Bruni, Gaetano Facchini, Claudia Marchetti, Sandro PignataOncologia Medica, Dipartimento Uro-Ginecologico, Istituto Nazionale Tumori, Napoli, ItalyAbstract: Epidemiologic analysis reveals that the mortality rate from ovarian ...
Carmela Pisano   +4 more
doaj  

BRCA1 Gene Q356R (1186A=G) Polymorphism and Epithelial Ovarian Cancer Incidence

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2015
Objective: To determine the association between BRCA1 gene Q356R (1186A=G) polymorphism and epithelial ovarian cancer incidence. Methods: This study is an observational analytic study with casecontrol study design.
Benyamin Rakhmatsyah   +3 more
doaj   +1 more source

Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells

open access: yesCancer Cell International, 2019
Background Abnormal activation of the classic Wnt signaling pathway is closely related to the occurrence of epithelial cancers. B-cell lymphoma 9 (BCL9), a transcription factor, is a novel oncogene discovered in the classic Wnt pathway and promotes the ...
Jing Wang   +9 more
doaj   +1 more source

Multiple metastases from ovarian cancer

open access: yesSouth African Journal of Obstetrics and Gynaecology, 2014
Epithelial ovarian cancer is one of the most common ovarian tumours. Ovarian cancer affects women in the age group >60 years much more frequently than younger women.
Daleep Singh   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy